Tuesday, 16 Jul 2019

You are here

Prevalence of gout

Lancet article on the increasing prevalence of gout shows a rate of 2.5% in the UK that has increased 67% in the last 15 years.  Nonetheless, fewer than half were counseled on the diagnosis or urate-lowering therapy and only 18% received urate-lowering treatment. In the U.S., the prevalence of gout has grown from 6/1000 in 1960 to 26/1000 in 2010;  rising from 1.1 million to 8.1 million in 2010.  [Image credit: "Fluorescent uric acid" by Bobjgalindo - Own work. Licensed under GFDL via Wikimedia Commons]

Disclosures: 
The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

Opioids Overused in Acute Gout

Opioids were commonly given to patients as a treatment for acute gout attacks, despite the availability of other effective and appropriate therapies, a retrospective study found.

Allopurinol Fails to Curtail Hypertension

Editor's note: July 1 - 5, RheumNow is running the best of the EULAR 2019 meeting. A novel trial presented at EULAR 2019 last week assessed whether the use of urate-lowering therapy (ULT) would control hypertension in those at risk; however, results of this trial were largely negative.

Hypertension is one of the many comorbidities that plagues gout patients.

Allopurinol Fails to Curtail Hypertension

A novel trial presented at EULAR 2019 last week assessed whether the use of urate-lowering therapy (ULT) would control hypertension in those at risk; however, results of this trial were largely negative.

Hypertension is one of the many comorbidities that plagues gout patients.

Updated 2018 EULAR Recommendations for the Diagnosis of Gout

The first EULAR recommendations for the diagnosis of gout were published in 2006. A task force was formed and following a systematic review, they voted unanimously for changes in all items of the 2006 recommendations.

Excess Non-CV Mortality Persists in Gout

Patients with gout not only have a well-recognized increased risk of dying from cardiovascular (CV) disease, but also have higher all-cause mortality and die prematurely from other diseases, a Swedish study indicated.